Exagen, Inc. (XGN)

3.77 +0.82 (+27.80%) USD  |  NASDAQ  |  May 11, 11:41
More

Exagen Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Veracyte, Inc. Upgrade
Insight Molecular Diagnostics, Inc. Upgrade
bioAffinity Technologies, Inc. --
GRAIL, Inc. Upgrade
FONAR Corp. --